US equities |
META $624.12 ▼-1.02% TSLA $405.78 ▲+3.61% MU $932.88 ▲+3.23% NVDA $218.06 ▲+0.95% SPCX $149.56 ▲+1.81% AMD $559.69 ▲+5.35% SNDK $1,302.72 ▲+3.75% AAPL $345.80 ▲+0.55%
FinancialContent

Latest News about Phase 3 Results

Recent news which mentions Phase 3 Results

Sanofi-SOBI Hemophilia Candidate Aces Late-Stage Study In Pretreated Patients
Tickers BIOVF SNY
Tags Hemophilia A Movers BIOVF
From Benzinga
Dupixent Becomes First Biologic To Show Benefit In Infant Patients With Atopic Dermatitis
Tickers REGN SNY
Tags News Benzinga General
From Benzinga